Healthcare Analysts Welford & Balchin, along with Dr Sagar Patel, Transplant & Cellular Therapy Program, Huntsman Cancer Institute, University of Utah, discuss GlaxoSmithKline (GSK) Ojjaara and Sobi’s Vonjo for Myelofibrosis on an Analyst/Industry conference call to be held on July 24 at 10 am. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSK:
- Down 60% in 3 Years, Will Moderna Stock (NASDAQ:MRNA) Fall Further?
- GSK reports EMA accepts marketing authoriaation application for Blenrep combos
- GSK Pharma call volume above normal and directionally bullish
- GSK begins shipping influenza vaccine doses for 2024-25 season
- GSK begins shipping doses of its trivalent influenza vaccines in U.S.